M. Heep

1.9k total citations
28 papers, 1.5k citations indexed

About

M. Heep is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, M. Heep has authored 28 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 18 papers in Epidemiology and 11 papers in Surgery. Recurrent topics in M. Heep's work include Antifungal resistance and susceptibility (9 papers), Helicobacter pylori-related gastroenterology studies (9 papers) and Mycobacterium research and diagnosis (7 papers). M. Heep is often cited by papers focused on Antifungal resistance and susceptibility (9 papers), Helicobacter pylori-related gastroenterology studies (9 papers) and Mycobacterium research and diagnosis (7 papers). M. Heep collaborates with scholars based in Germany, Switzerland and United States. M. Heep's co-authors include Norbert Lehn, Ulrich M. Rieger, Anne Schmitt‐Hoffmann, Brigitte Roos, Gary J. Noel, E. Bayerdörffer, E. Weidekamm, Thomas A. Brown, Stefan Niemann and Sabine Rüsch–Gerdes and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

M. Heep

28 papers receiving 1.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
M. Heep 1.1k 758 535 338 173 28 1.5k
Jacques Tankovic 522 0.5× 653 0.9× 575 1.1× 307 0.9× 478 2.8× 57 2.1k
Jin‐Yong Jeong 447 0.4× 529 0.7× 218 0.4× 59 0.2× 148 0.9× 47 1.4k
Farzad Khademi 360 0.3× 241 0.3× 238 0.4× 131 0.4× 56 0.3× 89 1.1k
K. J. Christiansen 491 0.5× 277 0.4× 231 0.4× 61 0.2× 77 0.4× 23 904
Erik Sturegård 728 0.7× 710 0.9× 467 0.9× 66 0.2× 74 0.4× 51 1.2k
M López-Brea 284 0.3× 283 0.4× 1.6k 2.9× 811 2.4× 78 0.5× 87 2.0k
Mohammad M. Feizabadi 508 0.5× 388 0.5× 154 0.3× 77 0.2× 83 0.5× 40 1.1k
Nobuhisa Yamane 398 0.4× 602 0.8× 141 0.3× 38 0.1× 160 0.9× 95 1.3k
Ting‐Shu Wu 479 0.5× 442 0.6× 140 0.3× 113 0.3× 36 0.2× 64 1.2k
Rodney Croos‐Dabrera 1.2k 1.1× 749 1.0× 61 0.1× 52 0.2× 195 1.1× 16 1.6k

Countries citing papers authored by M. Heep

Since Specialization
Citations

This map shows the geographic impact of M. Heep's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Heep with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Heep more than expected).

Fields of papers citing papers by M. Heep

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Heep. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Heep. The network helps show where M. Heep may publish in the future.

Co-authorship network of co-authors of M. Heep

This figure shows the co-authorship network connecting the top 25 collaborators of M. Heep. A scholar is included among the top collaborators of M. Heep based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Heep. M. Heep is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perfect, John R., Oliver A. Cornely, M. Heep, et al.. (2018). Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial. Mycoses. 61(7). 420–429. 24 indexed citations
2.
Seaton, R.A., K.N. Malizos, P. Viale, et al.. (2013). Daptomycin use in patients with osteomyelitis: a preliminary report from the EU-CORESM database. Journal of Antimicrobial Chemotherapy. 68(7). 1642–1649. 37 indexed citations
3.
4.
Dohmen, Pascal M., Achyut Guleri, Alessandro Capone, et al.. (2012). Daptomycin for the treatment of infective endocarditis: results from a European registry. Journal of Antimicrobial Chemotherapy. 68(4). 936–942. 30 indexed citations
5.
Verweij, Paul E., Gloria M. González, Nathan P. Wiederhold, et al.. (2009). In VitroAntifungal Activity of Isavuconazole against 345 Mucorales Isolates Collected at Study Centers in Eight Countries. Journal of Chemotherapy. 21(3). 272–281. 54 indexed citations
6.
Schmitt‐Hoffmann, Anne, Brigitte Roos, Jochen Spickermann, et al.. (2009). Effect of Mild and Moderate Liver Disease on the Pharmacokinetics of Isavuconazole after Intravenous and Oral Administration of a Single Dose of the Prodrug BAL8557. Antimicrobial Agents and Chemotherapy. 53(11). 4885–4890. 59 indexed citations
7.
Heep, M.. (2008). Pharmacokinetics, Safety and Tolerability Results of a Dose Escalation Study of Isavuconazole in Neutropenic Patients. 46th Annual Meeting. 1 indexed citations
8.
Heep, M., et al.. (2007). P1675 QTc measurements during a placebo- and actively controlled multiple dose study of two different dosing regimens of isavuconazole. International Journal of Antimicrobial Agents. 29. S474–S474. 2 indexed citations
9.
Schmitt‐Hoffmann, Anne, Brigitte Roos, & M. Heep. (2007). P987 Steady-state bioavailability of oral isavuconazole in healthy volunteers. International Journal of Antimicrobial Agents. 29. S262–S262. 5 indexed citations
10.
11.
Warn, Peter, Joanne Sharp, Juan Alejandro Neira Mosquera, et al.. (2006). Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus. Journal of Antimicrobial Chemotherapy. 58(6). 1198–1207. 71 indexed citations
12.
Heep, M., et al.. (2002). Detection of Rifabutin Resistance and Association of rpoB Mutations with Resistance to Four Rifamycin Derivatives in Helicobacter pylori. European Journal of Clinical Microbiology & Infectious Diseases. 21(2). 143–145. 21 indexed citations
13.
Heep, M., Ulrich M. Rieger, Norbert Lehn, et al.. (2001). Frequency of rpoB Mutations Inside and Outside the Cluster I Region in Rifampin-Resistant Clinical Mycobacterium tuberculosis Isolates. Journal of Clinical Microbiology. 39(1). 107–110. 194 indexed citations
14.
Böck, H., H. Koop, Norbert Lehn, & M. Heep. (2000). Rifabutin-based Triple Therapy After Failure of Helicobacter pylori Eradication Treatment. Journal of Clinical Gastroenterology. 31(3). 222–225. 85 indexed citations
15.
Heep, M., et al.. (2000). Secondary Resistance Among 554 Isolates of Helicobacter pylori After Failure of Therapy. European Journal of Clinical Microbiology & Infectious Diseases. 19(7). 538–541. 101 indexed citations
16.
Heep, M., Stefan Odenbreit, Jochen Decker, et al.. (2000). Mutations at Four Distinct Regions of the rpoB Gene Can Reduce the Susceptibility of Helicobacter pylori to Rifamycins. Antimicrobial Agents and Chemotherapy. 44(6). 1713–1715. 34 indexed citations
17.
Lohmann, Chris P., Virginie Gabel, M. Heep, H.‐J. Linde, & Udo Reischl. (1999). Listeria Monocytogenes-Induced Endogenous Endophthalmitis in an Otherwise Healthy Individual: Rapid PCR-Diagnosis as the Basis for Effective Treatment. European Journal of Ophthalmology. 9(1). 53–57. 21 indexed citations
18.
Heep, M., et al.. (1999). Rifampin and Rifabutin Resistance Mechanism in Helicobacter pylori. Antimicrobial Agents and Chemotherapy. 43(6). 1497–1499. 146 indexed citations
19.
Sachs, Helmut, M. Heep, & Veit‐Peter Gabel. (1998). Chirurgische Wurmentfernung bei Loa-Loa-Ophthalmie. Klinische Monatsblätter für Augenheilkunde. 213(12). 367–369. 7 indexed citations
20.
Lohmann, Chris P., M. Heep, Hans‐Jörg Linde, & Udo Reischl. (1998). Listeria monocytogenes- induzierte endogene Endophthalmitis bei einem sonst gesunden Individuum: PCR-gestützte Schnelldiagnostik als Grundlage für eine erfolgreiche Therapie. Klinische Monatsblätter für Augenheilkunde. 212(1). 55–58. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacques Tankovic Breakdown of academic impact, for papers by Jin‐Yong Jeong Breakdown of academic impact, for papers by Farzad Khademi Breakdown of academic impact, for papers by K. J. Christiansen Breakdown of academic impact, for papers by Erik Sturegård Breakdown of academic impact, for papers by M López-Brea Breakdown of academic impact, for papers by Mohammad M. Feizabadi Breakdown of academic impact, for papers by Nobuhisa Yamane Breakdown of academic impact, for papers by Ting‐Shu Wu Breakdown of academic impact, for papers by Rodney Croos‐Dabrera
Rankless by CCL
2026